Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Micrus Endovascular to get technology rights from ReVasc

Executive Summary

Micrus Endovascular (implants and devices for cerebral vascular conditions) has signed a letter of intent to acquire rights to an ischemic stroke treatment technology from ReVasc.

Deal Industry
  • Medical Devices
Deal Status
  • Preliminary
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies